SFSIG
GMAB icon

San Francisco Sentry Investment Group’s Genmab GMAB Stock Holding History

San Francisco Sentry Investment Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$42K Sell
1,018
-11
-1% -$424 0.02% 386
2021
Q1 		$34K Buy
1,029
+232
+29% +$8.72K 0.01% 428
2020
Q4 		$32K Buy
+797
New +$29.8K 0.02% 408

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

San Francisco Sentry Investment Group's GMAB Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its Genmab (GMAB) stake by 1.1% in Q2 2021, selling an estimated $424 and leaving 1,018 shares worth $42K. The position accounts for 0.02% of the portfolio, ranked #386.

San Francisco Sentry Investment Group first reported a position in GMAB in Q4 2020 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

  • San Francisco Sentry Investment Group held 1,018 shares of Genmab worth $42K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 11 Genmab shares in Q2 2021, an estimated $424.
  • Genmab made up 0.02% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #386 holding.
  • San Francisco Sentry Investment Group first reported a position in Genmab in Q4 2020 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.